Study in ICU Patients Regarding Protein Intake and CT-derived Body Composition

October 9, 2018 updated by: Wilhelmus G.P.M. Looijaard, MD, Amsterdam UMC, location VUmc

A Retrospective Investigator Initiated Trial Evaluating Protein Intake and CT Assessments of Muscle Mass of Critically Ill Patients in Relation to Outcome Parameters: the PROMUS-study

The purpose of this study is to determine whether protein intake during the first days of intensive care admission, in relation to body composition at intensive care admission as assessed on computed tomography scans made during routine care, is are related to clinical outcome in critically ill patients.

Study Overview

Detailed Description

Optimal protein and energy intake have been shown to be relevant for reducing mortality in prospective observational studies in mechanically ventilated patients admitted to the intensive care unit. However, nutritional status (protein mass, muscle mass) of patients at admission and possible consequences for clinical outcome are largely unknown. Computerized tomography scans can be used to assess muscle mass as a proxy for body protein mass.

The investigators are especially interested in the effect of protein intake on clinical outcome in intensive care patients with different body protein mass at admission. This is relevant for appropriate formulation of clinical (protein) nutrition in this patient group. Therefore, the relationship between protein intake and patient outcome is evaluated in intensive care patients with low muscle and normal muscle area, using muscle area from computed tomography scans as a proxy of body protein mass.

Additionally, data from computed tomography scans regarding muscle quality and muscle- and fat quantity are used to evaluate the prognostic value of body composition at intensive care admission. Finally, abdominal computed tomography scans are compared with thoracic computed tomography scans.

Study Type

Observational

Enrollment (Actual)

800

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients admitted to the intensive care unit

Description

Inclusion Criteria:

  • Abdominal computed tomography scan made 1 day before up to 4 days after admission to the intensive care unit
  • Length of intensive care stay of at least 4 days
  • Mechanical ventilation during intensive care stay

Exclusion Criteria:

  • Computed tomography scan not eligible for analysis
  • Missing data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Intensive care patients
Patients admitted to the intensive care unit for 4 days or more with a computed tomography scan made for clinical reasons early during intensive care stay and who receive enteral and/or parenteral nutrition as per hospital protocol
Patients were included if a computed tomography scan of the abdomen or thorax was made early during intensive care admission (1 day before up to 4 days after admission)
Patients received enteral and/or parenteral nutrition as per usual hospital protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
All-cause mortality
Time Frame: 6-months after intensive care admission
6-months after intensive care admission
All-cause mortality
Time Frame: 28-days after intensive care admission
28-days after intensive care admission
All-cause mortality
Time Frame: 60-days after intensive care admission
60-days after intensive care admission
All-cause mortality
Time Frame: 90-days after intensive care admission
90-days after intensive care admission
All-cause mortality
Time Frame: From admission to the intensive care unit untill discharge from the intensive care unit, an average of two weeks
From admission to the intensive care unit untill discharge from the intensive care unit, an average of two weeks
All-cause mortality
Time Frame: From admission to the intensive care unit untill discharge from the hospital, an average of one month
From admission to the intensive care unit untill discharge from the hospital, an average of one month

Secondary Outcome Measures

Outcome Measure
Time Frame
Percentage of patients discharged to home
Time Frame: After discharge from the hospital, on average after one month
After discharge from the hospital, on average after one month
Length of hospital stay (days)
Time Frame: The total duration of admission to the hospital, an average of one month
The total duration of admission to the hospital, an average of one month
Length of intensive care unit stay
Time Frame: The total duration of admission to the intensive care unit, an average of two weeks
The total duration of admission to the intensive care unit, an average of two weeks
Length of ventilation
Time Frame: The total duration of mechanical ventilation during intensive care unit stay, an average of 10 days
The total duration of mechanical ventilation during intensive care unit stay, an average of 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Peter J. Weijs, PhD, Amsterdam UMC, location VUmc

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

July 1, 2018

Study Registration Dates

First Submitted

June 23, 2016

First Submitted That Met QC Criteria

June 25, 2016

First Posted (Estimate)

June 29, 2016

Study Record Updates

Last Update Posted (Actual)

October 10, 2018

Last Update Submitted That Met QC Criteria

October 9, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscular Atrophy

Clinical Trials on Computed tomography scan made for clinical reasons

Subscribe